Exact Mass: 349.1426

Exact Mass Matches: 349.1426

Found 500 metabolites which its exact mass value is equals to given mass value 349.1426, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Ampicillin

(2S,5R,6R)-6-{[(2R)-2-amino-2-phenylethanoyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylIC ACID

C16H19N3O4S (349.1096)


Ampicillin is found in common pea. It is also a potential contaminant of cows milk arising from its veterinary use. Ampicillin is a semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. It has been used extensively to treat bacterial infections since 1961. It is considered part of the aminopenicillin family and is roughly equivalent to amoxicillin in terms of spectrum and level of activity J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic KEIO_ID A197

   

Fentrazamide

4-(2-chlorophenyl)-N-cyclohexyl-N-ethyl-5-oxo-4,5-dihydro-1H-1,2,3,4-tetrazole-1-carboxamide

C16H20ClN5O2 (349.1305)


   

Voriconazole

(AlphaR,betas)-alpha-(2,4-difluorophenyl)-5-fluoro-beta-methyl-alpha(1H-1,2,4-triazol-1-ylmethyl)-4-pyrimidineethanol

C16H14F3N5O (349.115)


Voriconazole (Vfend, Pfizer) is a triazole antifungal medication used to treat serious fungal infections. It is used to treat invasive fungal infections that are generally seen in patients who are immunocompromised. These include invasive candidiasis, invasive aspergillosis, and emerging fungal infections. J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Cefradine

(6R,7R)-7-{[(2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H19N3O4S (349.1096)


Cefradine is only found in individuals that have used or taken this drug. It is a semi-synthetic cephalosporin antibiotic.Cefradine is a first generation cephalosporin antibiotic with a spectrum of activity similar to Cefalexin. Cefradine, like the penicillins, is a beta-lactam antibiotic. By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, it inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Cefradine interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Riddelline

Riddelline; 18-Hydroxyseneciphylline

C18H23NO6 (349.1525)


   
   
   

Penicillin T

(p-Aminobenzyl)penicillin; Penicillin T

C16H19N3O4S (349.1096)


   

2-(Biaryl)carbapenems

2-(Biaryl)carbapenems

C21H19NO4 (349.1314)


   

Fenpropathrin

2,2,3,3-Tetramethylcyclopropanecarboxylic acid cyano(3-phenoxyphenyl)methyl ester

C22H23NO3 (349.1678)


D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins

   

Mitomycin A

SCHEMBL183170

C16H19N3O6 (349.1274)


A member of the family of mitomycins that exhibits antibiotic and antitumour properties as well as a high level of toxicity. C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins

   

Demethoxyfumitremorgin C

12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4(9),5,7-tetraene-14,20-dione

C21H23N3O2 (349.179)


Demethoxyfumitremorgin C is produced by Aspergillus fumigatu

   

R-138727

2-{1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-sulphanyl-1,2,5,6-tetrahydropyridin-3-yl}acetic acid

C18H20FNO3S (349.1148)


R-138727 is only found in individuals that have used or taken Prasugrel. R-138727 is a metabolite of Prasugrel. R-138727 belongs to the family of Phenylmethylamines. These are compounds containing a phenylmethtylamine moiety, which consists of a phenyl group substituted by an methanamine.

   

Pefloxacin N-oxide

3-carboxy-1-ethyl-6-fluoro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinolin-1-ium-1-olate

C17H20FN3O4 (349.1438)


Pefloxacin N-oxide is a metabolite of pefloxacin. Pefloxacin is a synthetic chemotherapeutic agent used to treat severe and life threatening bacterial infections. Pefloxacin is commonly referred to as a fluoroquinolone drug and is a member of the fluoroquinolone class of antibacterials. It is an analog of norfloxacin. It is a synthetic fluoroquinolone, belonging to the 3rd generation of quinolones. Pefloxacin is extensively prescribed in France. Pefloxacin has not been approved for use in the United States. (Wikipedia) D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine

3-{[5-(1,2-dithiolan-3-yl)pentanoyl]oxy}-4-(trimethylazaniumyl)butanoic acid

C15H27NO4S2 (349.1381)


5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine is an acylcarnitine. More specifically, it is an 5-[(3S)-1,2-dithiolan-3-yl]pentanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(3R,4S)-2-[6-(Cyclohexylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

(3R,4S)-2-[6-(Cyclohexylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O4 (349.175)


   

N-Hydroxy-3-[4-[[2-(2-methyl-1H-indol-3-yl)ethylamino]methyl]phenyl]-2-propenamide

N-Hydroxy3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enimidate

C21H23N3O2 (349.179)


   

Azasetron

N-(1-azabicyclo(2.2.2)Oct-3-yl)-6-chloro-4-methyl-3-oxo-3,4 -dihydro-2H-1,4-benzoxazine-8-carboxamide hydrochloride

C17H20ClN3O3 (349.1193)


   

BEFLOXATONE

5-(methoxymethyl)-3-[4-(4,4,4-trifluoro-3-hydroxybutoxy)phenyl]-1,3-oxazolidin-2-one

C15H18F3NO5 (349.1137)


   

Bisnor-(+)-S-145

5-(3-{[hydroxy(phenyl)phosphoryl]amino}bicyclo[2.2.1]heptan-2-yl)pent-3-enoic acid

C18H24NO4P (349.1443)


   

{1-[2-Cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-sulfanylpiperidin-3-ylidene}acetic acid

2-{1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-sulphanylpiperidin-3-ylidene}acetic acid

C18H20FNO3S (349.1148)


   

Cyclohexyladenosine

2-(6-amino-9H-purin-9-yl)-2-cyclohexyl-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O4 (349.175)


   

Dihydrochelerythrine

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1,3,8,10,12,14,16,18-octaene

C21H19NO4 (349.1314)


Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   

Emate

(13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl) sulfamate

C18H23NO4S (349.1348)


   

gamma-Glutamyl-5-hydroxytryptophan

4-Amino-4-{[1-carboxy-2-(5-hydroxy-1H-indol-3-yl)ethyl]-C-hydroxycarbonimidoyl}butanoate

C16H19N3O6 (349.1274)


   

Glutathione monoisopropyl ester

2-amino-4-[(1-{[2-oxo-2-(propan-2-yloxy)ethyl]carbamoyl}-2-sulfanylethyl)carbamoyl]butanoic acid

C13H23N3O6S (349.1307)


   

Mitomycin A

Azirino[2,3:3,4]pyrrolo[1,2-a]indole-4,7-dione, 1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-6,8a-dimethoxy-5-methyl-, carbamate (ester)

C16H19N3O6 (349.1274)


   

Pancopride

4-Amino-N-{1-azabicyclo[2.2.2]octan-3-yl}-5-chloro-2-(cyclopropylmethoxy)benzene-1-carboximidate

C18H24ClN3O2 (349.1557)


   

3-Quinolinecarboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-

3-Quinolinecarboxylic acid, 7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-

C17H17F2N3O3 (349.1238)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

Perampanel

3-(2-Cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one

C23H15N3O (349.1215)


N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

Riddelliine

4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H23NO6 (349.1525)


   

Texaphyrin

13,20,25,26,27-pentaazapentacyclo[20.2.1.1^{3,6}.1^{8,11}.0^{14,19}]heptacosa-1,3,5,7,9,11(26),12,14,16,18,20,22(25),23-tridecaene

C22H15N5 (349.1327)


   

tryptophan glutamate

4-amino-5-{[2-amino-3-(1H-indol-3-yl)propanoyl]peroxy}-5-oxopentanoic acid

C16H19N3O6 (349.1274)


   

Arachin

2-methoxy-6-[(2E)-4-(2-methylpiperidin-1-yl)-1,2-dihydroquinazolin-2-ylidene]cyclohexa-2,4-dien-1-one

C21H23N3O2 (349.179)


Arachin is a member of the class of compounds known as quinazolinamines. Quinazolinamines are heterocyclic aromatic compounds containing a quianazoline moiety substituted by one or more amine groups. Arachin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Arachin can be found in peanut, which makes arachin a potential biomarker for the consumption of this food product. Kodashim or Kodshim or Qodhashim (Hebrew: קדשים‎ "Holy Things") is the fifth Order in the Mishnah (also the Tosefta and Talmud). Of the six Orders of the Mishnah, it is the third longest. Kodoshim deals largely with the religious service within the Temple in Jerusalem, the qorbanot ("sacrificial offerings"), and other subjects considered or related to these "Holy Things" .

   

16, 17-dihydro-16alpha, 17-dihydroxy GA9

(2R,5R,6R,8R,9S,10R,11S)-6-hydroxy-6-(hydroxymethyl)-11-methyl-16-oxo-15-oxapentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane-9-carboxylate

C19H25O6- (349.1651)


16, 17-dihydro-16alpha, 17-dihydroxy ga9 is also known as 16α, 17-[oh]2 gibberellin a9. 16, 17-dihydro-16alpha, 17-dihydroxy ga9 is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 16, 17-dihydro-16alpha, 17-dihydroxy ga9 can be found in a number of food items such as spirulina, leek, tinda, and fenugreek, which makes 16, 17-dihydro-16alpha, 17-dihydroxy ga9 a potential biomarker for the consumption of these food products. 16, 17-dihydro-16α, 17-dihydroxy ga9 is also known as 16α, 17-[oh]2 gibberellin a9. 16, 17-dihydro-16α, 17-dihydroxy ga9 is slightly soluble (in water) and a weakly acidic compound (based on its pKa). 16, 17-dihydro-16α, 17-dihydroxy ga9 can be found in a number of food items such as spirulina, leek, tinda, and fenugreek, which makes 16, 17-dihydro-16α, 17-dihydroxy ga9 a potential biomarker for the consumption of these food products.

   

1ST14178

(3E,6R,14aR,14bR)-3-ethylidene-6-hydroxy-6-methyl-5-methylidene-12-oxo-3,4,5,6,11,12,13,14,14a,14b-decahydro-9H-12lambda(5)-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione

C18H23NO6 (349.1525)


Spartioidine N-oxide is a pyrrolizine alkaloid that is 13,19-didehydrosenecionane carrying a hydroxy substituent at position 12, two oxo substituents at positions 11 and 16 and an N-oxido substituent. It has a role as a Jacobaea metabolite. It is a macrocyclic lactone, an olefinic compound, an organic heterotricyclic compound, a pyrrolizine alkaloid, a tertiary alcohol and a tertiary amine oxide. It is functionally related to a spartioidine. Seneciphylline N-oxide is a natural product found in Jacobaea persoonii with data available. A pyrrolizine alkaloid that is 13,19-didehydrosenecionane carrying a hydroxy substituent at position 12, two oxo substituents at positions 11 and 16 and an N-oxido substituent.

   

Dihydrochelerythrine

1,2-Dimethoxy-12-methyl-12,13-dihydro-[1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine

C21H19NO4 (349.1314)


Dihydrochelerythrine is a benzophenanthridine alkaloid. Dihydrochelerythrine is a natural product found in Zanthoxylum coriaceum, Zanthoxylum gilletii, and other organisms with data available. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   

Seneciphylline N-oxide

Seneciphylline N-oxide

C18H23NO6 (349.1525)


A pyrrolizine alkaloid that is produced by a hybrid species of Jacobaea. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2279

   

12,13-Dihydroprolyl-2-(1,1-dimethylallyltryptophyl) diketopiperazine

12,13-Dihydroprolyl-2-(1,1-dimethylallyltryptophyl) diketopiperazine

C21H23N3O2 (349.179)


   

Dihydronitidine

(1,3)Benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-2,3-dimethoxy-12-methyl-

C21H19NO4 (349.1314)


   
   

methyl 7-(3-acetylamino-2,5-dihydroxyphenyl)-7-hydroxy-4,6-dimethyl-2,4-heptadienoate

methyl 7-(3-acetylamino-2,5-dihydroxyphenyl)-7-hydroxy-4,6-dimethyl-2,4-heptadienoate

C18H23NO6 (349.1525)


   
   
   

Foliosidine acetate

Foliosidine acetate

C18H23NO6 (349.1525)


   
   

Neoamphimedine Y

Neoamphimedine Y

C19H15N3O4 (349.1063)


   
   
   

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1h-indole-3-carboxamide

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1h-indole-3-carboxamide

C21H23N3O2 (349.179)


   

Azasetron

Azasetron

C17H20ClN3O3 (349.1193)


C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist > C94726 - 5-HT3 Receptor Antagonist D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   
   
   
   
   

Erucifoline

Erucifoline

C18H23NO6 (349.1525)


A pyrrolizine alkaloid that is produced by several Jacobaea species and displays toxicity towards insect herbivores. CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2300 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 174 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 164 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 154 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 144 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 134 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 124 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 114 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 104

   

Metazachlor-sulfinyl-acetic acid BH 479-9

Metazachlor-sulfinyl-acetic acid BH 479-9

C16H19N3O4S (349.1096)


   
   

Cyclo(-L-Trp-L-Tyr)

Cyclo(-L-Trp-L-Tyr)

C20H19N3O3 (349.1426)


   

3-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-1,2,3,4,6,7-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

3-[2-(1,1-Dimethyl-2-propenyl)-1H-indole-3-ylmethyl]-1,2,3,4,6,7-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione

C21H23N3O2 (349.179)


   

jacozine

jacozine

C18H23NO6 (349.1525)


A pyrrolizine alkaloid that is seneciphylline in which the exocyclic double bond has been converted to the corresponding epoxide.

   
   

3-O-methylorixine

3-O-methylorixine

C18H23NO6 (349.1525)


   

dechloroacutumidine

dechloroacutumidine

C18H23NO6 (349.1525)


   

tryptophan cis-4-aminocinnamamide

tryptophan cis-4-aminocinnamamide

C20H19N3O3 (349.1426)


   

19-(alpha-Methyl)-18-deoxy-15,22-dihydro-3-iso-cadamin|5-methyl-3,5,7,8,13,13b,14,14a-octahydro-indolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-1-carboxylic acid methyl ester

19-(alpha-Methyl)-18-deoxy-15,22-dihydro-3-iso-cadamin|5-methyl-3,5,7,8,13,13b,14,14a-octahydro-indolo[2,3:3,4]pyrido[1,2-b][2,7]naphthyridine-1-carboxylic acid methyl ester

C21H23N3O2 (349.179)


   
   
   

Tyloindicine E

Tyloindicine E

C22H23NO3 (349.1678)


   
   

2-(2-amino-beta-D-2-deoxy-gulopyranosylamino)-5-(2-amino-1-hydroxy-ethyl)-4,5-dihydro-1H-imidazole-4-carboxylic acid

2-(2-amino-beta-D-2-deoxy-gulopyranosylamino)-5-(2-amino-1-hydroxy-ethyl)-4,5-dihydro-1H-imidazole-4-carboxylic acid

C12H23N5O7 (349.1597)


   
   

(+)-(6aR,7R,E)-N-(but-2-enoyl)norushinsunine

(+)-(6aR,7R,E)-N-(but-2-enoyl)norushinsunine

C21H19NO4 (349.1314)


   

Buxifoliadine G

Buxifoliadine G

C21H19NO4 (349.1314)


   

brevianamide V

brevianamide V

C21H23N3O2 (349.179)


   

deoxydihydroisoaustamide

deoxydihydroisoaustamide

C21H23N3O2 (349.179)


   
   

2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4(1H)-quinolinone

2-[6-(1,3-Benzodioxole-5-yl)hexyl]-4(1H)-quinolinone

C22H23NO3 (349.1678)


   
   

Ochotensidine

Ochotensidine

C21H19NO4 (349.1314)


   
   

14beta,141-epoxy-15-hydroxy-14alpha-methyl-(15alphaH)-15,20-dihydro-21-nor-senecion-12(18)-ene-11,16-dione|Swazine

14beta,141-epoxy-15-hydroxy-14alpha-methyl-(15alphaH)-15,20-dihydro-21-nor-senecion-12(18)-ene-11,16-dione|Swazine

C18H23NO6 (349.1525)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

SCHEMBL11028909

SCHEMBL11028909

C14H19N7O4 (349.1498)


   
   
   
   
   
   
   
   
   
   

Riddelliine

(1,6)DIOXACYCLODODECINO(2,3,4-GH)PYRROLIZINE-2,7-DIONE, 3-ETHYLIDENE-3,4,5,6,9,11,13,14,14A,14B-DECAHYDRO-6-HYDROXY-6-(HYDROXYMETHYL)-5-METHYLENE-, (6S-(3Z,6R*,14AS*,14BS*))-

C18H23NO6 (349.1525)


Riddelline is a colorless to off-white crystalline solid. Starts turning brown at approximately 329 °F; is blackish-brown at melting point. (NTP, 1992) Riddelliine is a macrodiolide that is 13,19-didehydrosenecionan bearing two additional hydroxy substituents at positions 12 and 18 as well as two additional oxo groups at positions 11 and 16. It has a role as a genotoxin, a mutagen and a carcinogenic agent. It is a pyrrolizine alkaloid, an organic heterotricyclic compound, an olefinic compound and a macrodiolide. It is functionally related to a senecionan. Riddelliine is a natural product found in Senecio aegyptius, Senecio glaucus, and other organisms with data available. A macrodiolide that is 13,19-didehydrosenecionan bearing two additional hydroxy substituents at positions 12 and 18 as well as two additional oxo groups at positions 11 and 16.

   

Norisoboldine hydrochloride

4H-Dibenzo[de,g]quinoline-1,9-diol, 5,6,6a,7-tetrahydro-2,10-dimethoxy-, hydrochloride, (S)-

C18H20ClNO4 (349.1081)


   

Laurolitsine hydrochloride

(6aS)-1,10-dimethoxy-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol;hydrochloride

C18H20ClNO4 (349.1081)


   

Erucifoline

(5R,9Z,12R,18R)-9-Ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.05,7.015,18]octadec-1(17)-ene-4,10-dione

C18H23NO6 (349.1525)


CID 6442624 is a natural product found in Jacobaea aquatica with data available.

   

Ampicillin

Ampicillin

C16H19N3O4S (349.1096)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum A penicillin in which the substituent at position 6 of the penam ring is a 2-amino-2-phenylacetamido group. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic relative retention time with respect to 9-anthracene Carboxylic Acid is 0.412 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.411 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3661 EAWAG_UCHEM_ID 3661; CONFIDENCE standard compound

   

Voriconazole

Voriconazole Vfend

C16H14F3N5O (349.115)


J - Antiinfectives for systemic use > J02 - Antimycotics for systemic use > J02A - Antimycotics for systemic use > J02AC - Triazole and tetrazole derivatives D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D065088 - Steroid Synthesis Inhibitors D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065692 - Cytochrome P-450 CYP3A Inhibitors D004791 - Enzyme Inhibitors > D065088 - Steroid Synthesis Inhibitors > D058888 - 14-alpha Demethylase Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   
   
   
   
   

Metazachlor BH 479-9

Metazachlor BH 479-9

C16H19N3O4S (349.1096)


CONFIDENCE standard compound; INTERNAL_ID 2649

   

3,N4-Epoxyoctenal-deoxycytidine

3,N4-Epoxyoctenal-deoxycytidine

C17H23N3O5 (349.1638)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

R-138727

2-{1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-sulfanyl-1,2,5,6-tetrahydropyridin-3-yl}acetic acid

C18H20FNO3S (349.1148)


   

(4-(N-Ethyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

(4-(N-Ethyl-N-(4-methoxybenzyl)sulfamoyl)phenyl)boronic acid

C16H20BNO5S (349.1155)


   

Oxarbazole

Oxarbazole

C21H19NO4 (349.1314)


C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

   

Sematilide hydrochloride

Sematilide hydrochloride

C14H24ClN3O3S (349.1227)


   

5-(2,6-DIFLUOROPHENYL)TETRAZOLE

5-(2,6-DIFLUOROPHENYL)TETRAZOLE

C18H27NO4Si (349.1709)


   
   

Copper bis(2-ethylhexanoate)

Copper bis(2-ethylhexanoate)

C16H30CuO4 (349.144)


   
   

(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

C16H14F3N5O (349.115)


   

2-Acetamido-4-fluoro-1,3,6-tri-O-acetyl-2,4-dideoxy-D-glucopyranose

2-Acetamido-4-fluoro-1,3,6-tri-O-acetyl-2,4-dideoxy-D-glucopyranose

C14H20FNO8 (349.1173)


   

rel-(R,R)-Voriconazole

rel-(R,R)-Voriconazole

C16H14F3N5O (349.115)


   

METHYL 3-CYCLOHEXYL-2-(2-HYDROXYPHENYL)-1H-INDOLE-6-CARBOXYLATE

METHYL 3-CYCLOHEXYL-2-(2-HYDROXYPHENYL)-1H-INDOLE-6-CARBOXYLATE

C22H23NO3 (349.1678)


   

CP-466722

1-(6,7-dimethoxyquinazolin-4-yl)-3-(pyridin-2-yl)-1H-1,2,4-triazol-5-amine

C17H15N7O2 (349.1287)


   

2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride

2-Amino-4,5-bis(2-methoxyethoxy)benzoic acid ethyl ester hydrochloride

C15H24ClNO6 (349.1292)


   

6-amino-2-chloropurine

6-amino-2-chloropurine

C19H16ClN5 (349.1094)


   

Fmoc-(S)-3-Amino-5-hexynoic acid

Fmoc-(S)-3-Amino-5-hexynoic acid

C21H19NO4 (349.1314)


   

Hexanoic acid,2-ethyl-, copper salt (2:1)

Hexanoic acid,2-ethyl-, copper salt (2:1)

C16H30CuO4 (349.144)


   

N-FMOC-GUVACINE

N-FMOC-GUVACINE

C21H19NO4 (349.1314)


   
   

HL-Asp(Bzl)-OBzl * HCl

HL-Asp(Bzl)-OBzl * HCl

C18H20ClNO4 (349.1081)


   

2-AMINO-1-BENZYL-4,5-DIPHENYL-1H-PYRROLE-3-CARBONITRILE

2-AMINO-1-BENZYL-4,5-DIPHENYL-1H-PYRROLE-3-CARBONITRILE

C24H19N3 (349.1579)


   

H-D-Asp(Obzl)-Obzl.HCl

H-D-Asp(Obzl)-Obzl.HCl

C18H20ClNO4 (349.1081)


   

Resminostat

Resminostat

C16H19N3O4S (349.1096)


C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   
   

Befloxatone

Befloxatone

C15H18F3NO5 (349.1137)


C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor

   

1-BOC-4-(4-AMINOPHENYL)PIPERAZINE DIHYDROCHLORIDE

1-BOC-4-(4-AMINOPHENYL)PIPERAZINE DIHYDROCHLORIDE

C15H25Cl2N3O2 (349.1324)


   

(-)-(1s,4r)-n-fmoc-4-aminocyclopent-2-enecarboxylic acid

(-)-(1s,4r)-n-fmoc-4-aminocyclopent-2-enecarboxylic acid

C21H19NO4 (349.1314)


   

(3S,4R)-1-BENZYL-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-BENZYL-4-(4-(TRIFLUOROMETHYL)PHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C19H18F3NO2 (349.129)


   

benzyl N-(3-cyano-6-methoxy-4-oxo-1H-quinolin-7-yl)carbamate

benzyl N-(3-cyano-6-methoxy-4-oxo-1H-quinolin-7-yl)carbamate

C19H15N3O4 (349.1063)


   

(2S,3R)-N-TERT-BUTOXYCARBONYL-3-BENZOYLOXY-2-PYRROLIDINECARBOXYLICACIDMETHYLESTER

(2S,3R)-N-TERT-BUTOXYCARBONYL-3-BENZOYLOXY-2-PYRROLIDINECARBOXYLICACIDMETHYLESTER

C18H23NO6 (349.1525)


   

[R-(R*,S*)]-3-[(2-hydroxy-1-methyl-2-phenylethyl)amino]-3-methoxypropiophenone hydrochloride

[R-(R*,S*)]-3-[(2-hydroxy-1-methyl-2-phenylethyl)amino]-3-methoxypropiophenone hydrochloride

C19H24ClNO3 (349.1445)


   

R 138727

(2Z)-2-[1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-sulfanylpiperidin-3-ylidene]acetic acid

C18H20FNO3S (349.1148)


   

fmoc-(r)-3-amino-5-hexynoic acid

fmoc-(r)-3-amino-5-hexynoic acid

C21H19NO4 (349.1314)


   

4-[Bis(4-methoxyphenyl)amino]benzoic acid

4-[Bis(4-methoxyphenyl)amino]benzoic acid

C21H19NO4 (349.1314)


   

2-Methyl-2-propanyl (11-bromoundecyl)carbamate

2-Methyl-2-propanyl (11-bromoundecyl)carbamate

C16H32BrNO2 (349.1616)


   

3,8-Diamino-5-ethyl-6-phenylphenanthridinium chl

3,8-Diamino-5-ethyl-6-phenylphenanthridinium chl

C21H20ClN3 (349.1346)


   

2-CYCLOHEXYL-1-OXO-3-PHENYL-1,2,3,4-TETRAHYDRO-4-ISOQUINOLINECARBOXYLIC ACID

2-CYCLOHEXYL-1-OXO-3-PHENYL-1,2,3,4-TETRAHYDRO-4-ISOQUINOLINECARBOXYLIC ACID

C22H23NO3 (349.1678)


   

triphenyl(trimethylsilylimino)-λ5-phosphane

triphenyl(trimethylsilylimino)-λ5-phosphane

C21H24NPSi (349.1416)


   

Cinmetacin

1H-Indole-3-aceticacid, 5-methoxy-2-methyl-1-(1-oxo-3-phenyl-2-propen-1-yl)-

C21H19NO4 (349.1314)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

   

ETHYL 5-HYDROXY-7-OXO-2-PHENYL-8-(PROP-2-YNYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

ETHYL 5-HYDROXY-7-OXO-2-PHENYL-8-(PROP-2-YNYL)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C19H15N3O4 (349.1063)


   

4-CYCLOHEXYL-5-(3,4,5-TRIMETHOXY-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

4-CYCLOHEXYL-5-(3,4,5-TRIMETHOXY-PHENYL)-4H-[1,2,4]TRIAZOLE-3-THIOL

C17H23N3O3S (349.146)


   

(4-PIPERAZIN-1-YL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER DIHYDROCHLORIDE

(4-PIPERAZIN-1-YL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER DIHYDROCHLORIDE

C15H25Cl2N3O2 (349.1324)


   
   

N-Cyclopentyl-2-C-methyladenosine

N-Cyclopentyl-2-C-methyladenosine

C16H23N5O4 (349.175)


   

DIETHYL 2-(1-(4-ACETAMIDOPHENYL)-1-OXOPROPAN-2-YL)MALONATE

DIETHYL 2-(1-(4-ACETAMIDOPHENYL)-1-OXOPROPAN-2-YL)MALONATE

C18H23NO6 (349.1525)


   

copper(II) isooctanoate

copper(II) isooctanoate

C16H30CuO4 (349.144)


   

boc-asp(obzl)-n-carboxyanhydride

boc-asp(obzl)-n-carboxyanhydride

C17H19NO7 (349.1161)


   

Z-ALA-BETA-NAPHTHYL ESTER

Z-ALA-BETA-NAPHTHYL ESTER

C21H19NO4 (349.1314)


   

(1S,3R)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxamide

(1S,3R)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxamide

C20H19N3O3 (349.1426)


   

ent-Voriconazole

ent-Voriconazole

C16H14F3N5O (349.115)


   

Boronic acid, B-[4-[bis(4-methoxyphenyl)amino]phenyl]-

Boronic acid, B-[4-[bis(4-methoxyphenyl)amino]phenyl]-

C20H20BNO4 (349.1485)


   

(R)-N-Fmoc-2-(2-propynyl)alanine

(R)-N-Fmoc-2-(2-propynyl)alanine

C21H19NO4 (349.1314)


   

tert-butyl 4-(4-aMinophenyl)piperazine-1-carboxylate dihydrochloride

tert-butyl 4-(4-aMinophenyl)piperazine-1-carboxylate dihydrochloride

C15H25Cl2N3O2 (349.1324)


   

Z-3-(1-naphthyl)-L-alanine

Z-3-(1-naphthyl)-L-alanine

C21H19NO4 (349.1314)


   

Cyclobutanemethanamine, 1-(3,4-dichlorophenyl)-N,N-dimethyl-α-(2-methylpropyl)-, hydrochloride ()

Cyclobutanemethanamine, 1-(3,4-dichlorophenyl)-N,N-dimethyl-α-(2-methylpropyl)-, hydrochloride ()

C17H26Cl3N (349.1131)


   
   

(S)-N-FMoc-2-(2--propynyl)alanine

(S)-N-FMoc-2-(2--propynyl)alanine

C21H19NO4 (349.1314)


   

Beryllium bis[2-(2-pyridinyl)phenolate]

Beryllium bis[2-(2-pyridinyl)phenolate]

C22H16BeN2O2 (349.1334)


   

Fmoc-L-propargylalanine

Fmoc-L-propargylalanine

C21H19NO4 (349.1314)


   

Adenosine,2,3-O-(1-methylethylidene)-, 5-acetate

Adenosine,2,3-O-(1-methylethylidene)-, 5-acetate

C15H19N5O5 (349.1386)


   

Desethylene Gatifloxacin

Desethylene Gatifloxacin

C17H20FN3O4 (349.1438)


   

N6-Cyclohexyladenosine

N6-Cyclohexyladenosine

C16H23N5O4 (349.175)


N6-Cyclohexyladenosine is a selective adenosine A1 receptor agonist (EC50 = 8.2 nM). N6-Cyclohexyladenosine is a selective adenosine A1 receptor agonist (EC50 = 8.2 nM).

   

2-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-nitrobenzoic acid ethyl ester

2-[[(1,1-Dimethylethoxy)carbonyl]amino]-3-nitrobenzoic acid ethyl ester

C16H14F3N5O (349.115)


   

3-{[(4-Methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate

3-{[(4-Methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate

C16H19N3O4S (349.1096)


   

(4-fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol

(4-fluorophenyl)(4-((5-methyl-1H-pyrazol-3-yl)amino)quinazolin-2-yl)methanol

C19H16FN5O (349.1339)


   
   

Biphenamine hydrochloride

Biphenamine hydrochloride

C19H24ClNO3 (349.1445)


C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

Mitomycin B

Mitomycin B

C16H19N3O6 (349.1274)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents > D000903 - Antibiotics, Antineoplastic > D008937 - Mitomycins A member of the family of mitomycins that exhibits antibiotic and antitumour properties.

   

PAPP

PAPP

C19H22F3N3 (349.1766)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists LY 165163 is a potent 5-HT presynaptic receptor agonist. LY 165163 significantly decreases 5-HTP accumulation and increases DOPA accumulation in the cortex and striatum[1].

   
   

5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide

5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide

C17H23N3O3S (349.146)


   

Oxayohimbanium, 3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyl-, (19alpha,20alpha)-

Oxayohimbanium, 3,4,5,6,16,17-hexadehydro-16-(methoxycarbonyl)-19-methyl-, (19alpha,20alpha)-

C21H21N2O3+ (349.1552)


   

3-(2-Oxolanylmethylthio)-5,6-diphenyl-1,2,4-triazine

3-(2-Oxolanylmethylthio)-5,6-diphenyl-1,2,4-triazine

C20H19N3OS (349.1249)


   

6-(benzo[d][1,3]dioxol-5-yl)-N-((tetrahydrofuran-3-yl)methyl)quinazolin-4-amine

6-(benzo[d][1,3]dioxol-5-yl)-N-((tetrahydrofuran-3-yl)methyl)quinazolin-4-amine

C20H19N3O3 (349.1426)


   

N-(1,3-benzodioxol-5-yl)-2,3-diethyl-6-quinoxalinecarboxamide

N-(1,3-benzodioxol-5-yl)-2,3-diethyl-6-quinoxalinecarboxamide

C20H19N3O3 (349.1426)


   

2-phenoxy-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]acetamide

2-phenoxy-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]acetamide

C20H19N3O3 (349.1426)


   

2-[[2-(3-Methyl-2-methylimino-4-oxo-5-thiazolidinyl)-1-oxoethyl]amino]benzoic acid ethyl ester

2-[[2-(3-Methyl-2-methylimino-4-oxo-5-thiazolidinyl)-1-oxoethyl]amino]benzoic acid ethyl ester

C16H19N3O4S (349.1096)


   

(E)-N-(furan-2-ylmethyl)-2-(3,4,5-trimethoxybenzylidene)hydrazinecarbothioamide

(E)-N-(furan-2-ylmethyl)-2-(3,4,5-trimethoxybenzylidene)hydrazinecarbothioamide

C16H19N3O4S (349.1096)


   

2-[[5-(4-Ethoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(4-morpholinyl)ethanone

2-[[5-(4-Ethoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(4-morpholinyl)ethanone

C16H19N3O4S (349.1096)


   
   
   

L-Seryl-L-prolyl-L-phenylalanine

L-Seryl-L-prolyl-L-phenylalanine

C17H23N3O5 (349.1638)


   

L-Prolyl-L-seryl-L-phenylalanine

L-Prolyl-L-seryl-L-phenylalanine

C17H23N3O5 (349.1638)


   

4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide

4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide

C16H17F2N5O2 (349.135)


   

Chromophore (Met-Tyr-Gly)

Chromophore (Met-Tyr-Gly)

C16H19N3O4S (349.1096)


   

Perampanel

Perampanel

C23H15N3O (349.1215)


N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   

AIDS-106788

(1,3)Benzodioxolo(5,6-c)phenanthridine, 12,13-dihydro-1,2-dimethoxy-12-methyl-

C21H19NO4 (349.1314)


Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3]. Dihydrochelerythrine is a natural compound isolated from Corydalis yanhusuo; has antifungal activity. IC50 value: Target: in vitro: Dihydrochelerythrine showed the highest antifungal activity against B. cinerea Pers, with 98.32\% mycelial growth inhibition at 50 μg/mL. Dihydrochelerythrine inhibited spore germination in vitro in a concentration-dependent manner [1]. Dihydrochelerythrine appeared to be less cytotoxic since the viability of cells exposed to 20 microM dihydrochelerythrine for 24h was reduced only to 53\%. A dose-dependent induction of apoptosis and necrosis by chelerythrine and dihydrochelerythrine was confirmed by annexin V/propidium iodide dual staining flow cytometry [2]. Dihydrochelerythrine (4) exhibited strong activity against methicillin-resistant Staphylococcus aureus SK1 and moderate activity against Escherichia coli TISTR 780 with MIC values of 8 and 16 μg/mL, respectively [3].

   
   
   

3-(2-chlorophenyl)-2,5-dimethyl-N-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine

3-(2-chlorophenyl)-2,5-dimethyl-N-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidin-7-amine

C19H16ClN5 (349.1094)


   
   

3,8,9-Trimethoxy-5-methylbenzo[c]phenanthridin-2-one

3,8,9-Trimethoxy-5-methylbenzo[c]phenanthridin-2-one

C21H19NO4 (349.1314)


   

estrone 3-sulfate

estrone 3-sulfate

C18H21O5S- (349.111)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

(6R,7R)-7-[[(2R)-2-azaniumyl-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

(6R,7R)-7-[[(2R)-2-azaniumyl-2-cyclohexa-1,4-dien-1-ylacetyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C16H19N3O4S (349.1096)


   

(2S,5R,6R)-6-[[(2R)-2-azaniumyl-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

(2S,5R,6R)-6-[[(2R)-2-azaniumyl-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C16H19N3O4S (349.1096)


   

16alpha, 17-[OH]2 gibberellin A9

16alpha, 17-[OH]2 gibberellin A9

C19H25O6- (349.1651)


   
   

5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine

5-[(3S)-1,2-Dithiolan-3-yl]pentanoylcarnitine

C15H27NO4S2 (349.1381)


   

4-amino-5-[2-amino-3-(1H-indol-3-yl)propanoyl]peroxy-5-oxopentanoic acid

4-amino-5-[2-amino-3-(1H-indol-3-yl)propanoyl]peroxy-5-oxopentanoic acid

C16H19N3O6 (349.1274)


   

(E)-5-[3-[(hydroxy-oxido-phenylphosphaniumyl)amino]-2-bicyclo[2.2.1]heptanyl]pent-3-enoic acid

(E)-5-[3-[(hydroxy-oxido-phenylphosphaniumyl)amino]-2-bicyclo[2.2.1]heptanyl]pent-3-enoic acid

C18H24NO4P (349.1443)


   

(4E)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

(4E)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione

C18H23NO6 (349.1525)


   
   

N-(4-methoxyphenyl)-2-(phenylmethylthio)benzamide

N-(4-methoxyphenyl)-2-(phenylmethylthio)benzamide

C21H19NO2S (349.1136)


   

{[(2,6-difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide

{[(2,6-difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide

C16H17F2N5O2 (349.135)


   

CID 13258912

Seneciphylline N-oxide

C18H23NO6 (349.1525)


   

Cathestatin A

Cathestatin A

C17H23N3O5 (349.1638)


A dicarboxylic acid monoamide obtained by the formal condensation of the carboxylic group of oxirane-2,3-dicarboxylic acid with the amino group of N-(4-aminobutyl)-L-phenylalaninamide (the 2S,3S stereoisomer). An antibiotic isolated from the fermentation broth of Penicillium citrinum, it acts as a potent inhibitor of cysteine protease.

   

Tetrazolium violet(1+)

Tetrazolium violet(1+)

C23H17N4+ (349.1453)


   

6-(1,3-benzodioxol-5-yl)-N-(2-oxolanylmethyl)-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-(2-oxolanylmethyl)-4-quinazolinamine

C20H19N3O3 (349.1426)


   

2-Furanyl-[4-(4-tetrazolo[1,5-a]quinoxalinyl)-1-piperazinyl]methanone

2-Furanyl-[4-(4-tetrazolo[1,5-a]quinoxalinyl)-1-piperazinyl]methanone

C17H15N7O2 (349.1287)


   
   
   

3-(5-chloro-2-methylphenyl)-6-(2,6-dimethyl-4-morpholinyl)-1H-pyrimidine-2,4-dione

3-(5-chloro-2-methylphenyl)-6-(2,6-dimethyl-4-morpholinyl)-1H-pyrimidine-2,4-dione

C17H20ClN3O3 (349.1193)


   

2-(2-Methoxyphenyl)-5-[2-(4-methoxyphenyl)ethylamino]-4-oxazolecarbonitrile

2-(2-Methoxyphenyl)-5-[2-(4-methoxyphenyl)ethylamino]-4-oxazolecarbonitrile

C20H19N3O3 (349.1426)


   

N-(2-methoxyphenyl)-2-phenyl-2-(phenylthio)acetamide

N-(2-methoxyphenyl)-2-phenyl-2-(phenylthio)acetamide

C21H19NO2S (349.1136)


   

N-(2-oxolanylmethyl)-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

N-(2-oxolanylmethyl)-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

C20H19N3O3 (349.1426)


   

2-[(2-methyl-2,3-dihydroindol-1-yl)methyl]-4-oxo-1H-quinazoline-7-carboxylic acid methyl ester

2-[(2-methyl-2,3-dihydroindol-1-yl)methyl]-4-oxo-1H-quinazoline-7-carboxylic acid methyl ester

C20H19N3O3 (349.1426)


   

N-[[(2,4-dimethyl-8-quinolinyl)amino]-sulfanylidenemethyl]-4-methylbenzamide

N-[[(2,4-dimethyl-8-quinolinyl)amino]-sulfanylidenemethyl]-4-methylbenzamide

C20H19N3OS (349.1249)


   

N-{(E)-[5-(4-nitrophenyl)furan-2-yl]methylidene}-2-phenylacetohydrazide

N-{(E)-[5-(4-nitrophenyl)furan-2-yl]methylidene}-2-phenylacetohydrazide

C19H15N3O4 (349.1063)


   

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(3,5-dimethyl-1-pyrazolyl)benzamide

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(3,5-dimethyl-1-pyrazolyl)benzamide

C20H19N3O3 (349.1426)


   

N-[1-oxo-3-phenyl-1-(2-pyridinylmethylamino)propan-2-yl]-2-furancarboxamide

N-[1-oxo-3-phenyl-1-(2-pyridinylmethylamino)propan-2-yl]-2-furancarboxamide

C20H19N3O3 (349.1426)


   

1-(2-methylphenyl)-3-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)thiourea

1-(2-methylphenyl)-3-(6,7,8,9-tetrahydro-5H-carbazol-3-ylmethyl)thiourea

C21H23N3S (349.1613)


   

6-[(2,5-Dimethylphenyl)methyl]-3-(4-fluorophenyl)-7-triazolo[4,5-d]pyrimidinone

6-[(2,5-Dimethylphenyl)methyl]-3-(4-fluorophenyl)-7-triazolo[4,5-d]pyrimidinone

C19H16FN5O (349.1339)


   

methyl (5E)-5-[(4-hydroxyphenyl)methylidene]-2-methyl-1-(4-methylphenyl)-4-oxopyrrole-3-carboxylate

methyl (5E)-5-[(4-hydroxyphenyl)methylidene]-2-methyl-1-(4-methylphenyl)-4-oxopyrrole-3-carboxylate

C21H19NO4 (349.1314)


   

N-[(2-hydroxy-1-naphthalenyl)-(4-methoxyphenyl)methyl]-2-methylpropanamide

N-[(2-hydroxy-1-naphthalenyl)-(4-methoxyphenyl)methyl]-2-methylpropanamide

C22H23NO3 (349.1678)


   

N-{(1E)-[4-(methylthio)phenyl]methylene}-2-(2-naphthylamino)acetohydrazide

N-{(1E)-[4-(methylthio)phenyl]methylene}-2-(2-naphthylamino)acetohydrazide

C20H19N3OS (349.1249)


   

N-naphthalen-2-yl-2-[(E)-(3-nitrophenyl)methylideneamino]oxyacetamide

N-naphthalen-2-yl-2-[(E)-(3-nitrophenyl)methylideneamino]oxyacetamide

C19H15N3O4 (349.1063)


   

(15R)-13-(Furan-2-ylmethyl)-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

(15R)-13-(Furan-2-ylmethyl)-10,10-dimethyl-8,11,13-triazatetracyclo[7.7.0.02,7.011,15]hexadeca-1(9),2,4,6-tetraene-12,14-dione

C20H19N3O3 (349.1426)


   

6-(1,3-benzodioxol-5-yl)-N-[[(2S)-2-oxolanyl]methyl]-4-quinazolinamine

6-(1,3-benzodioxol-5-yl)-N-[[(2S)-2-oxolanyl]methyl]-4-quinazolinamine

C20H19N3O3 (349.1426)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol;chloride

(1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol;chloride

C19H24ClNO3 (349.1445)


   

(2S,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1,2,4-triazol-1-yl)-2-butanol

(2S,3S)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1,2,4-triazol-1-yl)-2-butanol

C16H14F3N5O (349.115)


   

4-fluoro-N-[4-(4-methylpiperazin-1-yl)phenyl]benzenesulfonamide

4-fluoro-N-[4-(4-methylpiperazin-1-yl)phenyl]benzenesulfonamide

C17H20FN3O2S (349.126)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

3-(2-Chloro-7-hydroxy-10-phenothiazinyl)propyl-trimethylammonium

3-(2-Chloro-7-hydroxy-10-phenothiazinyl)propyl-trimethylammonium

C18H22ClN2OS+ (349.1141)


   

(2S)-4-[(E)-2-[5-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-3-ium-3-yl]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

(2S)-4-[(E)-2-[5-[(2S)-2-amino-2-carboxyethyl]-1H-imidazol-3-ium-3-yl]ethenyl]-2,3-dihydropyridine-2,6-dicarboxylic acid

C15H17N4O6+ (349.1148)


   

[(4S,6S,7R)-13-hydroxy-7,11-dimethoxy-12-methyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

[(4S,6S,7R)-13-hydroxy-7,11-dimethoxy-12-methyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

C16H19N3O6 (349.1274)


   

[(4S,6S,7R)-7,13-dihydroxy-11-methoxy-5,12-dimethyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

[(4S,6S,7R)-7,13-dihydroxy-11-methoxy-5,12-dimethyl-10-oxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(13),8,11-trien-8-yl]methyl carbamate

C16H19N3O6 (349.1274)


   

(9E)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.05,7.015,18]octadec-1(17)-ene-4,10-dione

(9E)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.05,7.015,18]octadec-1(17)-ene-4,10-dione

C18H23NO6 (349.1525)


   

N-Acetylglycylphenylalanylalanine methyl ester

N-Acetylglycylphenylalanylalanine methyl ester

C17H23N3O5 (349.1638)


   

N-Acetylalanylphenylalanylglycine methyl ester

N-Acetylalanylphenylalanylglycine methyl ester

C17H23N3O5 (349.1638)


   

2-Ethoxycarbonyl-3,4-dimethoxycarbonyl-1-methyl-5-phenylpyrrolidine (2,3-trans-3,4,5-cis)

2-Ethoxycarbonyl-3,4-dimethoxycarbonyl-1-methyl-5-phenylpyrrolidine (2,3-trans-3,4,5-cis)

C18H23NO6 (349.1525)


   

2-Ethoxycarbonyl-3,4-dimethoxycarbonyl-1-methyl-5-phenylpyrrolidine (2,3,5-cis-4,5-trans)

2-Ethoxycarbonyl-3,4-dimethoxycarbonyl-1-methyl-5-phenylpyrrolidine (2,3,5-cis-4,5-trans)

C18H23NO6 (349.1525)


   

N-Acetyl-alanyl-phenylalanyl-glycine methylester

N-Acetyl-alanyl-phenylalanyl-glycine methylester

C17H23N3O5 (349.1638)


   

Fenpropathrin

fenpropathrin [ANSI]

C22H23NO3 (349.1678)


D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins

   

Cefradine

Cephradine

C16H19N3O4S (349.1096)


A cephalosporin with a methyl substituent at position 3, and a (2R)-2-amino-2-cyclohexa-1,4-dien-1-ylacetamido substituent at position 7, of the cephem skeleton. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   
   

Pefloxacin N-oxide

Pefloxacin N-oxide

C17H20FN3O4 (349.1438)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones

   

2-[6-(Cyclohexylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[6-(Cyclohexylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C16H23N5O4 (349.175)


   
   

estrone 3-sulfate(1-)

estrone 3-sulfate(1-)

C18H21O5S (349.111)


The conjugate base of estrone 3-sulfate; major species at pH 7.3.

   

alstonine(1+)

alstonine(1+)

C21H21N2O3 (349.1552)


An organic cation resulting from the protonation of the carbonilide moiety of alstonine. The major microspecies at pH 7.3.

   

serpentine(1+)

serpentine(1+)

C21H21N2O3 (349.1552)


An organic cation that is the conjugate acid of serpentine. It is the major species at pH 7.3.

   

Oblongine chloride

Oblongine chloride

C19H24ClNO3 (349.1445)


   
   
   
   

CFMTI

CFMTI

C19H16FN5O (349.1339)


CFMTI inhibits L-glutamate-induced intracellular Ca2+ mobilization in CHO cells expressing human and rat mGluR1a, with IC50s of 2.6 and 2.3 nM, respectively[1].

   

Laurolitsine (hydrochloride)

Laurolitsine (hydrochloride)

C18H20ClNO4 (349.1081)


Laurolitsine hydrochloride is an alkaloid isolated from Phoebe formosana, and shows weak anti-inflammatory activity.

   

Laurolitsine (hydrochloride)

Laurolitsine (hydrochloride)

C18H20ClNO4 (349.1081)


Laurolitsine hydrochloride is an alkaloid isolated from Phoebe formosana, and shows weak anti-inflammatory activity.

   

ML289

ML289

C22H23NO3 (349.1678)


ML289 (VU0463597) is a potent, selective, and CNS-penetrant mGlu3 (IC50=0.66 μM) negative allosteric modulator. ML289 displays >15-fold selectivity over mGlu2 and is inactive against mGlu5[1]. ML289 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

(3r,4r)-3,4,8-trihydroxy-5-methyl-5,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1,7,9,11,13(21),14,16,18-octaen-6-one

(3r,4r)-3,4,8-trihydroxy-5-methyl-5,10,20-triazapentacyclo[11.7.1.0²,⁷.0⁹,²¹.0¹⁴,¹⁹]henicosa-1,7,9,11,13(21),14,16,18-octaen-6-one

C19H15N3O4 (349.1063)


   

(5r,7s,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

(5r,7s,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

C18H23NO6 (349.1525)


   

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

C21H19NO4 (349.1314)


   

11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

C20H19N3O3 (349.1426)


   

3-(3-hydroxy-3-methyl-2-oxobutyl)-4,7,8-trimethoxy-1-methylquinolin-2-one

3-(3-hydroxy-3-methyl-2-oxobutyl)-4,7,8-trimethoxy-1-methylquinolin-2-one

C18H23NO6 (349.1525)


   

(2e)-3-phenyl-n-(4-{[(2e)-3-phenylprop-2-enoyl]oxy}butyl)prop-2-enimidic acid

(2e)-3-phenyl-n-(4-{[(2e)-3-phenylprop-2-enoyl]oxy}butyl)prop-2-enimidic acid

C22H23NO3 (349.1678)


   

(1'r,2s,3s,7'r,17'r)-7'-hydroxy-3,7'-dimethyl-6'-methylidene-2',9'-dioxa-14'-azaspiro[oxirane-2,4'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

(1'r,2s,3s,7'r,17'r)-7'-hydroxy-3,7'-dimethyl-6'-methylidene-2',9'-dioxa-14'-azaspiro[oxirane-2,4'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

C18H23NO6 (349.1525)


   

(9e)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

(9e)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

C18H23NO6 (349.1525)


   

3,8,9-trimethoxy-5-methylcyclohexa[c]phenanthridin-2-one

3,8,9-trimethoxy-5-methylcyclohexa[c]phenanthridin-2-one

C21H19NO4 (349.1314)


   

(20r)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

(20r)-5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

methyl 2-(methylamino)-5-[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

methyl 2-(methylamino)-5-[(3s)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

C20H19N3O3 (349.1426)


   

(1r,1's,5s,6's)-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

(1r,1's,5s,6's)-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C18H23NO6 (349.1525)


   

(20r)-4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

(20r)-4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

[(1s,3s,4s,7r,8s,9r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,6-diazapentacyclo[7.4.0.0¹,⁶.0²,⁴.0³,⁷]tridec-11-en-8-yl]methoxycarboximidic acid

[(1s,3s,4s,7r,8s,9r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,6-diazapentacyclo[7.4.0.0¹,⁶.0²,⁴.0³,⁷]tridec-11-en-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

(2s)-2-{[(2e)-3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(2e)-3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C20H19N3O3 (349.1426)


   

2-({2-[(4-carbamimidamido-1-carboxy-3-hydroxybutyl)amino]ethyl}amino)butanedioic acid

2-({2-[(4-carbamimidamido-1-carboxy-3-hydroxybutyl)amino]ethyl}amino)butanedioic acid

C12H23N5O7 (349.1597)


   

5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

5,11-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

[(3s,4s,7r,8r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,6-diazatetracyclo[7.4.0.0²,⁴.0³,⁷]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(3s,4s,7r,8r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,6-diazatetracyclo[7.4.0.0²,⁴.0³,⁷]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

methyl (3e)-6-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-4-methylhex-3-enoate

methyl (3e)-6-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-4-methylhex-3-enoate

C18H23NO6 (349.1525)


   

3-hydroxy-1-[(4-methoxy-1-methyl-2-oxoquinolin-8-yl)oxy]-3-methylbutan-2-yl acetate

3-hydroxy-1-[(4-methoxy-1-methyl-2-oxoquinolin-8-yl)oxy]-3-methylbutan-2-yl acetate

C18H23NO6 (349.1525)


   

9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

C18H23NO6 (349.1525)


   

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

17,18-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14,16,18-octaene

C21H19NO4 (349.1314)


   

methyl 6-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-4-methylhex-3-enoate

methyl 6-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-4-methylhex-3-enoate

C18H23NO6 (349.1525)


   

n-[3,7-dihydroxy-2-(2-methyl-3-oxopent-1-en-1-yl)-2,3,4,5-tetrahydro-1-benzoxepin-9-yl]-2-hydroxyethanimidic acid

n-[3,7-dihydroxy-2-(2-methyl-3-oxopent-1-en-1-yl)-2,3,4,5-tetrahydro-1-benzoxepin-9-yl]-2-hydroxyethanimidic acid

C18H23NO6 (349.1525)


   

(1'r,2s,4'z,7'r,17'r)-4'-ethylidene-7'-hydroxy-7'-methyl-2',9'-dioxa-14'-azaspiro[oxirane-2,6'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

(1'r,2s,4'z,7'r,17'r)-4'-ethylidene-7'-hydroxy-7'-methyl-2',9'-dioxa-14'-azaspiro[oxirane-2,6'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

C18H23NO6 (349.1525)


   

3-({1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

3-({1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid

C17H23N3O5 (349.1638)


   

(2s,5r,6r)-6-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

(2s,5r,6r)-6-{[(2r)-2-amino-1-hydroxy-2-phenylethylidene]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid

C16H19N3O4S (349.1096)


   

3-phenyl-n-{4-[(3-phenylprop-2-enoyl)oxy]butyl}prop-2-enimidic acid

3-phenyl-n-{4-[(3-phenylprop-2-enoyl)oxy]butyl}prop-2-enimidic acid

C22H23NO3 (349.1678)


   

(2r)-2-[(2-{[(1s,3r)-4-carbamimidamido-1-carboxy-3-hydroxybutyl]amino}ethyl)amino]butanedioic acid

(2r)-2-[(2-{[(1s,3r)-4-carbamimidamido-1-carboxy-3-hydroxybutyl]amino}ethyl)amino]butanedioic acid

C12H23N5O7 (349.1597)


   

(1s,1's,5s,6's)-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

(1s,1's,5s,6's)-5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C18H23NO6 (349.1525)


   

2-[6-(2h-1,3-benzodioxol-5-yl)hexyl]-1h-quinolin-4-one

2-[6-(2h-1,3-benzodioxol-5-yl)hexyl]-1h-quinolin-4-one

C22H23NO3 (349.1678)


   

[(4s,6s,7r,8r)-7-hydroxy-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(4s,6s,7r,8r)-7-hydroxy-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

methyl (4e)-6-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-4-methylhex-4-enoate

methyl (4e)-6-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-4-methylhex-4-enoate

C18H23NO6 (349.1525)


   

(1r,4z,7s,14r,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate

(1r,4z,7s,14r,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate

C18H23NO6 (349.1525)


   

2-{[3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

2-{[3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C20H19N3O3 (349.1426)


   

(2s)-2-{[(2z)-3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

(2s)-2-{[(2z)-3-(4-aminophenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-3-(1h-indol-3-yl)propanoic acid

C20H19N3O3 (349.1426)


   

(5r,7r,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

(5r,7r,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

C18H23NO6 (349.1525)


   

(1'r,2s,4'e,7'r,17'r)-4'-ethylidene-7'-hydroxy-7'-methyl-2',9'-dioxa-14'-azaspiro[oxirane-2,6'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

(1'r,2s,4'e,7'r,17'r)-4'-ethylidene-7'-hydroxy-7'-methyl-2',9'-dioxa-14'-azaspiro[oxirane-2,6'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

C18H23NO6 (349.1525)


   

3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C20H19N3O3 (349.1426)


   

1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methoxy-3-methylbutan-2-ol

1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methoxy-3-methylbutan-2-ol

C18H23NO6 (349.1525)


   

(20s)-4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

(20s)-4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

4'-ethylidene-7'-hydroxy-7'-methyl-2',9'-dioxa-14'-azaspiro[oxirane-2,6'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

4'-ethylidene-7'-hydroxy-7'-methyl-2',9'-dioxa-14'-azaspiro[oxirane-2,6'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

C18H23NO6 (349.1525)


   

[(4s,6s,7r,8s)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(4s,6s,7r,8s)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

(1r,4e,7s,17r)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1r,4e,7s,17r)-4-ethylidene-7-hydroxy-7-(hydroxymethyl)-6-methylidene-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C18H23NO6 (349.1525)


   

(2e)-1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

(2e)-1-[(12r,13r)-13-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]but-2-en-1-one

C21H19NO4 (349.1314)


   

methyl 2-(methylamino)-5-[(3r)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

methyl 2-(methylamino)-5-[(3r)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]benzoate

C20H19N3O3 (349.1426)


   

(1'r,2s,5'r,7'r,17'r)-7'-hydroxy-5',7'-dimethyl-4'-methylidene-2',9'-dioxa-14'-azaspiro[oxirane-2,6'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

(1'r,2s,5'r,7'r,17'r)-7'-hydroxy-5',7'-dimethyl-4'-methylidene-2',9'-dioxa-14'-azaspiro[oxirane-2,6'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

C18H23NO6 (349.1525)


   

(7s,8s)-11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

(7s,8s)-11,13-dihydroxy-8-(1h-indol-3-yl)-3,9-diazatricyclo[8.4.0.0³,⁷]tetradeca-1(14),10,12-trien-2-one

C20H19N3O3 (349.1426)


   

methyl (2r,4s,5s,6r)-6-(3-ethyl-4-methoxyindol-1-yl)-4,5-dihydroxyoxane-2-carboxylate

methyl (2r,4s,5s,6r)-6-(3-ethyl-4-methoxyindol-1-yl)-4,5-dihydroxyoxane-2-carboxylate

C18H23NO6 (349.1525)


   

(1r,4z,7s,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate

(1r,4z,7s,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate

C18H23NO6 (349.1525)


   

7'-hydroxy-3,7'-dimethyl-6'-methylidene-2',9'-dioxa-14'-azaspiro[oxirane-2,4'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

7'-hydroxy-3,7'-dimethyl-6'-methylidene-2',9'-dioxa-14'-azaspiro[oxirane-2,4'-tricyclo[9.5.1.0¹⁴,¹⁷]heptadecan]-11'-ene-3',8'-dione

C18H23NO6 (349.1525)


   

4-(2-hydroxy-3,4,5-trimethoxybenzoyl)-3-(methylamino)benzene-1,2-diol

4-(2-hydroxy-3,4,5-trimethoxybenzoyl)-3-(methylamino)benzene-1,2-diol

C17H19NO7 (349.1161)


   

n-{2,5-dihydroxy-3-[(3e,5e)-1-hydroxy-7-methoxy-2,4-dimethyl-7-oxohepta-3,5-dien-1-yl]phenyl}ethanimidic acid

n-{2,5-dihydroxy-3-[(3e,5e)-1-hydroxy-7-methoxy-2,4-dimethyl-7-oxohepta-3,5-dien-1-yl]phenyl}ethanimidic acid

C18H23NO6 (349.1525)


   

(2r)-3-hydroxy-1-[(4-methoxy-1-methyl-2-oxoquinolin-8-yl)oxy]-3-methylbutan-2-yl acetate

(2r)-3-hydroxy-1-[(4-methoxy-1-methyl-2-oxoquinolin-8-yl)oxy]-3-methylbutan-2-yl acetate

C18H23NO6 (349.1525)


   

5-(4-hydroxyphenyl)-1-methyl-3-[2-(methylamino)ethyl]-7h-pyrrolo[3,2-f]indole-4,8-dione

5-(4-hydroxyphenyl)-1-methyl-3-[2-(methylamino)ethyl]-7h-pyrrolo[3,2-f]indole-4,8-dione

C20H19N3O3 (349.1426)


   

n-[(2r,3s)-3,7-dihydroxy-2-(2-methyl-3-oxopent-1-en-1-yl)-2,3,4,5-tetrahydro-1-benzoxepin-9-yl]-2-hydroxyethanimidic acid

n-[(2r,3s)-3,7-dihydroxy-2-(2-methyl-3-oxopent-1-en-1-yl)-2,3,4,5-tetrahydro-1-benzoxepin-9-yl]-2-hydroxyethanimidic acid

C18H23NO6 (349.1525)


   

(1r,4z,7r,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate

(1r,4z,7r,17r)-4-ethylidene-7-hydroxy-7-methyl-6-methylidene-3,8-dioxo-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-en-14-ium-14-olate

C18H23NO6 (349.1525)


   

methyl 6-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-4-methylhex-4-enoate

methyl 6-[4,6-dihydroxy-2-(2-hydroxyethyl)-1-oxo-3h-isoindol-5-yl]-4-methylhex-4-enoate

C18H23NO6 (349.1525)


   

5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

5-hydroxy-2',3',4-trimethoxy-10'-azaspiro[cyclopentane-1,7'-tricyclo[4.3.3.0¹,⁶]dodecane]-2',3-diene-2,4'-dione

C18H23NO6 (349.1525)


   

2-imino-7-methoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-6-ol

2-imino-7-methoxy-4-(4-methoxyphenyl)-1-methyl-3h-naphtho[2,3-d]imidazol-6-ol

C20H19N3O3 (349.1426)


   

4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

4,5-dimethoxy-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaen-10-ol

C22H23NO3 (349.1678)


   

(3s,6r)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3s,6r)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C20H19N3O3 (349.1426)


   

[(4r,6r,7s,8r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(4r,6r,7s,8r)-7,11-dimethoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

ethyl 2-{[(3r)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

ethyl 2-{[(3r)-9-oxo-1h,2h,3h-pyrrolo[2,1-b]quinazolin-3-yl]amino}benzoate

C20H19N3O3 (349.1426)


   

(5s,7r,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

(5s,7r,9z,12r,18r)-9-ethylidene-7-(hydroxymethyl)-5-methyl-3,6,11-trioxa-15-azatetracyclo[10.5.1.0⁵,⁷.0¹⁵,¹⁸]octadec-1(17)-ene-4,10-dione

C18H23NO6 (349.1525)


   

(2r)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methoxy-3-methylbutan-2-ol

(2r)-1-{6,8-dimethoxy-2h-[1,3]dioxolo[4,5-h]quinolin-7-yl}-3-methoxy-3-methylbutan-2-ol

C18H23NO6 (349.1525)


   

(2s,3s)-3-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

(2s,3s)-3-{[(1s)-1-[(4-aminobutyl)-c-hydroxycarbonimidoyl]-2-phenylethyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

C17H23N3O5 (349.1638)


   

(3s,6s)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

(3s,6s)-3-[(4-hydroxyphenyl)methyl]-6-(1h-indol-3-ylmethyl)-3,6-dihydropyrazine-2,5-diol

C20H19N3O3 (349.1426)


   

(2s)-3-hydroxy-1-[(4-methoxy-1-methyl-2-oxoquinolin-8-yl)oxy]-3-methylbutan-2-yl acetate

(2s)-3-hydroxy-1-[(4-methoxy-1-methyl-2-oxoquinolin-8-yl)oxy]-3-methylbutan-2-yl acetate

C18H23NO6 (349.1525)


   

16,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene

16,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2,4(8),9,11,14(19),15,17-octaene

C21H19NO4 (349.1314)


   

[(7r,8r)-7-hydroxy-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

[(7r,8r)-7-hydroxy-11-methoxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0²,⁷.0⁴,⁶]trideca-1(9),11-dien-8-yl]methoxycarboximidic acid

C16H19N3O6 (349.1274)


   

6-methyl-6'-methylidene-2',7,8,8'-tetrahydro-2h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxole]

6-methyl-6'-methylidene-2',7,8,8'-tetrahydro-2h-spiro[[1,3]dioxolo[4,5-g]isoquinoline-5,7'-indeno[4,5-d][1,3]dioxole]

C21H19NO4 (349.1314)